Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Help
Clear All

Query Builder

Query box

Help
Clear All

For additional assistance using the Custom Query please check out our Help Page

Morbidity and Mortality Weekly Report (MMWR) Morbidity and Mortality Weekly Report (MMWR)
Morbidity and Mortality Weekly Report (MMWR)

The Morbidity and Mortality Weekly Report (MMWR) series is CDC’s primary vehicle for scientific publication of timely, reliable, authoritative, accurate, objective, and useful public health information and recommendations. The MMWR series includes the following publications: MMWR Weekly, MMWR Recommendations and Reports, CDC Surveillance Summaries and MMWR Supplements.

Narrow Results:
Volume
More
Publish Year
More
Genre
More
Document Type
More
Location
More
7681 - 7700 of 8244 Results
SAVE BULK CITATIONS
Refine Results
All Collections
Small Close Icon
Refine Results:
All Collections
Small Close Icon
Next
    Suppl.EMENTARY FIGURE 1.. SARS-CoV-2 B.1.1.529 (Omicron) Variant Transmission Within Households – Four U.S. Jurisdictions, November 2021-February 2022
    Cite
    Filetype[PDF - 48.12 KB]
    Personal Author:
    Centers for Disease Control and Prevention (U.S.)
    02/25/2022
    No Description
    File Type:
    Filetype[PDF - 48.12 KB]
    File Type:
    Filetype[PDF - 48.12 KB]
    Disparities in COVID-19 Vaccination Coverage Between Urban and Rural Counties — U.S. December 14, 2020–January 31, 2022
    Cite
    Filetype[PDF - 142.46 KB]
    Personal Author:
    Saelee, Ryan ;
    Zell, Elizabeth
    ...
    3 04 2022 | MMWR Morb Mortal Wkly Rep. 71(9):335-340
    Description:
    Higher COVID-19 incidence and Mortality rates in rural than in urban areas are well documented (1). These disparities persisted during the B.1.617.2 (...
    File Type:
    Filetype[PDF - 142.46 KB]
    File Type:
    Filetype[PDF - 142.46 KB]
    SARS-CoV-2 B.1.1.529 (Omicron) Variant Transmission Within Households — Four U.S. Jurisdictions, November 2021–February 2022
    Cite
    Filetype[PDF - 166.18 KB]
    Personal Author:
    Baker, Julia M. ;
    Nakayama, Jasmine Y.
    ...
    3 04 2022 | MMWR Morb Mortal Wkly Rep. 71(9):341-346
    Description:
    The B.1.1.529 (Omicron) Variants, first detected in November 2021, was responsible for a surge in U.S. infections with SARS-CoV-2, the Virus that caus...
    File Type:
    Filetype[PDF - 166.18 KB]
    File Type:
    Filetype[PDF - 166.18 KB]
    Geospatial Transmission Hotspots of Recent HIV Infection — Malawi, October 2019–March 2020
    Cite
    Filetype[PDF - 1.69 MB]
    Personal Author:
    Telford, Carson T. ;
    Tessema, Zaena
    ...
    3 04 2022 | MMWR Morb Mortal Wkly Rep. 71(9):329-334
    Description:
    Persons infected with HIV are more likely to transmit the Virus during the early stages (acute and recent) of infection, when viral load is elevated a...
    File Type:
    Filetype[PDF - 1.69 MB]
    File Type:
    Filetype[PDF - 1.69 MB]
    Safety Monitoring of COVID-19 Vaccine Booster Doses Among Persons Aged 12–17 Years — U.S. December 9, 2021–February 20, 2022
    Cite
    Filetype[PDF - 125.25 KB]
    Personal Author:
    Hause, Anne M. ;
    Baggs, James
    ...
    3 04 2022 | MMWR Morb Mortal Wkly Rep. 71(9):347-351
    Description:
    As of February 20, 2022, only BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine has been authorized for use in persons aged 12-17 years in the U.S. (1). The...
    File Type:
    Filetype[PDF - 125.25 KB]
    File Type:
    Filetype[PDF - 125.25 KB]
    Notes from the Field: Readiness for Use of Type 2 Novel Oral PolioVirus Vaccine in Response to a Type 2 Circulating Vaccine-Derived PolioVirus Outbreak — Tajikistan, 2020–2021
    Cite
    Filetype[PDF - 98.01 KB]
    Personal Author:
    O’Connor, Patrick ;
    Huseynov, Shahin
    ...
    3 04 2022 | MMWR Morb Mortal Wkly Rep. 71(9):361-362
    No Description
    File Type:
    Filetype[PDF - 98.01 KB]
    File Type:
    Filetype[PDF - 98.01 KB]
    Suppl.EMENTARY FIGURE 2. SARS-CoV-2 B.1.1.529 (Omicron) Variant Transmission Within Households – Four U.S. Jurisdictions, November 2021-February 2022
    Cite
    Filetype[PDF - 161.25 KB]
    Personal Author:
    Centers for Disease Control and Prevention (U.S.)
    02/25/2022
    No Description
    File Type:
    Filetype[PDF - 161.25 KB]
    File Type:
    Filetype[PDF - 161.25 KB]
    Surveillance for Sickle Cell Disease — Sickle Cell Data Collection Program, Two States, 2004–2018
    Cite
    Filetype[PDF - 454.21 KB]
    Personal Author:
    Snyder, Angela B. ;
    Lakshmanan, Sangeetha
    ...
    10 07 2022 | MMWR Surveill Summ. 71(9):1-18
    Description:
    Problem/ConditionSickle cell disease (SCD), an inherited blood disorder affecting an estimated 100,000 persons in the United States, is associated wit...
    File Type:
    Filetype[PDF - 454.21 KB]
    File Type:
    Filetype[PDF - 454.21 KB]
    Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5–17 Years — VISION Network, 10 States, April 2021–January 2022
    Cite
    Filetype[PDF - 162.02 KB]
    Personal Author:
    Klein, Nicola P. ;
    Stockwell, Melissa S.
    ...
    3 04 2022 | MMWR Morb Mortal Wkly Rep. 71(9):352-358
    Description:
    The efficacy of the BNT162b2 (Pfizer-BioNTech) vaccine against laboratory-confirmed COVID-19 exceeded 90% in clinical trials that included children an...
    File Type:
    Filetype[PDF - 162.02 KB]
    File Type:
    Filetype[PDF - 162.02 KB]
    Notes from the Field: First Reports of Locally Transmitted Seoul HantaVirus Infection — District of Columbia, May 2018–December 2018
    Cite
    Filetype[PDF - 70.56 KB]
    Personal Author:
    Ravi-Caldwell, Nivedita ;
    Iyengar, Preetha
    ...
    3 04 2022 | MMWR Morb Mortal Wkly Rep. 71(9):359-360
    No Description
    File Type:
    Filetype[PDF - 70.56 KB]
    File Type:
    Filetype[PDF - 70.56 KB]
    QuickStats: Percentage of Adults Aged ≥18 Years with Kidney Disease, by Age Group and Sex — National Health Interview Survey, United States, July–December 2020
    Cite
    Filetype[PDF - 70.55 KB]
    Personal Author:
    Weeks, Julie D. ;
    Elgaddal, Nazik
    3 04 2022 | QuickStats
    Description:
    During July–December 2020, 3.1% of adults aged ≥18 years had kidney disease. The prevalence of kidney disease increased with age, from 1.1% among ...
    File Type:
    Filetype[PDF - 70.55 KB]
    File Type:
    Filetype[PDF - 70.55 KB]
    Characteristics and Adverse Events of Patients for Whom Nifurtimox Was Released Through CDC-Sponsored Investigational New Drug Program for Treatment of Chagas Disease — U.S. 2001–2021
    Cite
    Filetype[PDF - 232.13 KB]
    Personal Author:
    Abbott, Andrew ;
    Montgomery, Susan P.
    ...
    3 11 2022 | MMWR Morb Mortal Wkly Rep. 71(10):371-374
    Description:
    Chagas disease, or American trypanosomiasis, is caused by the parasite Trypanosoma cruzi. Chagas disease is endemic in rural areas of Latin America, b...
    File Type:
    Filetype[PDF - 232.13 KB]
    File Type:
    Filetype[PDF - 232.13 KB]
    QuickStats: Percentage of Adults Aged ≥18 Years Who Sleep <7 Hours on Average in a 24-Hour Period, by Sex and Age Group — National Health Interview Survey, U.S. 2020
    Cite
    Filetype[PDF - 76.31 KB]
    Personal Author:
    Adjaye-Gbewonyo, Dzifa ;
    Ng, Amanda E.
    ...
    3 11 2022 | QuickStats
    Description:
    Overall, 28.3% of men and 27.2% of women aged ≥18 years slept <7 hours on average within a 24-hour period. Among persons aged 18–44 years, men (28...
    File Type:
    Filetype[PDF - 76.31 KB]
    File Type:
    Filetype[PDF - 76.31 KB]
    MMWR MMWR Weekly Report, Vol. 71, March 11, 2022
    Cite
    Filetype[PDF - 671.63 KB]
    :
    Centers for Disease Control and Prevention (U.S.)
    03/11/2022 | MMWR; v. 71, no. 10
    No Description
    File Type:
    Filetype[PDF - 671.63 KB]
    File Type:
    Filetype[PDF - 671.63 KB]
    SARS-CoV-2 Incidence In Mask-Required K–12 School Districts Compared with Mask-Optional School Districts — Arkansas, August–October 2021
    Cite
    Filetype[PDF - 16.40 KB]
    Personal Author:
    Centers for Disease Control and Prevention (U.S.)
    03/08/2022
    No Description
    File Type:
    Filetype[PDF - 16.40 KB]
    File Type:
    Filetype[PDF - 16.40 KB]
    Suppl.ementary tables for: COVID-19 Vaccine Provider Access and Vaccination Coverage Among Children Aged 5–11 years — U.S. November 2021–January 2022
    Cite
    Filetype[PDF - 156.65 KB]
    :
    Centers for Disease Control and Prevention (U.S.)
    03/11/2022 | MMWR Morb Mortal Wkly Rep 2022;71:378–383.
    Description:
    Suppl.ementary tables for: Kim C, Yee R, Bhatkoti R, et al. COVID-19 Vaccine Provider Access and Vaccination Coverage Among Children Aged 5–11 Years...
    File Type:
    Filetype[PDF - 156.65 KB]
    File Type:
    Filetype[PDF - 156.65 KB]
    COVID-19 Vaccine Provider Access and Vaccination Coverage Among Children Aged 5–11 Years — United States, November 2021–January 2022
    Cite
    Filetype[PDF - 189.40 KB]
    Personal Author:
    Kim, Christine ;
    Yee, Randy
    ...
    3 11 2022 | MMWR Morb Mortal Wkly Rep. 71(10):378-383
    Description:
    On October 29, 2021, the Pfizer-BioNTech pediatric COVID-19 vaccine received Emergency Use Authorization for children aged 5-11 years in the United St...
    File Type:
    Filetype[PDF - 189.40 KB]
    File Type:
    Filetype[PDF - 189.40 KB]
    Interim Estimates of 2021–22 Seasonal Influenza Vaccine Effectiveness — United States, February 2022
    Cite
    Filetype[PDF - 257.56 KB]
    Personal Author:
    Chung, Jessie R. ;
    Kim, Sara S.
    ...
    3 11 2022 | MMWR Morb Mortal Wkly Rep. 71(10):365-370
    Description:
    In the United States, annual vaccination against seasonal influenza is recommended for all persons aged ≥6 months except when contraindicated (1). C...
    File Type:
    Filetype[PDF - 257.56 KB]
    File Type:
    Filetype[PDF - 257.56 KB]
    SARS-CoV-2 Incidence in K–12 School Districts with Mask-Required Versus Mask-Optional Policies — Arkansas, August–October 2021
    Cite
    Filetype[PDF - 210.53 KB]
    Personal Author:
    Donovan, Catherine V. ;
    Rose, Charles
    ...
    3 11 2022 | MMWR Morb Mortal Wkly Rep. 71(10):384-389
    Description:
    Masks are effective at limiting Transmission of SARS-CoV-2, the Virus that causes COVID-19 (1), but the impact of policies requiring masks in school s...
    File Type:
    Filetype[PDF - 210.53 KB]
    File Type:
    Filetype[PDF - 210.53 KB]
    Notes from the Field: Congenital Varicella Syndrome Case — Illinois, 2021
    Cite
    Filetype[PDF - 149.17 KB]
    Personal Author:
    Leung, Jessica ;
    Reid, Heather D.
    ...
    3 11 2022 | MMWR Morb Mortal Wkly Rep. 71(10):390-392
    No Description
    File Type:
    Filetype[PDF - 149.17 KB]
    File Type:
    Filetype[PDF - 149.17 KB]
7681 - 7700 / 8244
Sort By:
Refine Results:
All Collections
Small Close Icon